Skip to content

Negative Pressure Incisional Wound Therapy for High-risk Ventral Hernia Repair

Negative Pressure Incisional Wound Therapy for High-risk Ventral Hernia Repair: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04455724
Acronym
N-PITH
Enrollment
110
Registered
2020-07-02
Start date
2020-12-14
Completion date
2024-05-01
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventral Hernia

Brief summary

The investigators are testing the ability of vacuum dressings to improve wound healing for patients having large hernias surgically repaired who are at risk of having wound complications. The trial will randomly be giving some patients having this surgery the vacuum dressing and some a standard dressing and observing how their wounds heal in hospital and at follow-up appointments.

Detailed description

This study is a multicentre, clinical randomized controlled trial comparing the use of incisional negative pressure wound therapy versus standard sterile dressings in high-risk ventral hernia repairs. The trial will be enrolling patients undergoing elective or emergent ventral hernia repair who have risk factors for surgical wound complications and randomizing them to either receive a PREVENA incisional negative pressure wound therapy system dressing for 7 days post-operatively or a standard sterile dressing.for 2 days post-operatively. The primary outcome will be a composite of a variety of surgical site complications including wound infection, dehiscence, seroma / hematoma formation, non-healing wound, early hernia recurrence, and fistula formation. These will be evaluated by unblinded clinical judgement of treating physicians, and blinded assessment with ultrasonography. Secondary outcomes will include perceived difference in Quality of Life and cost-effectiveness of the intervention.

Interventions

DEVICENegative pressure incisional wound therapy

A vacuum-style dressing system that is sealed in place over a surgical wound, applying constant negative pressure to the healing tissues.

A standard, sterile island dressing

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Given the physical differences in the negative pressure wound therapy systems compared to standard sterile dressings, patient participants and care providers will not be able to be blinded. Ultrasound evaluators and statisticians, however, will be.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. patients undergoing surgical repair of ventral or incisional hernias greater than 3 cm in largest diameter 2. have one or more of the following risk factors for post-operative surgical site complications: 1. Body Mass Index (BMI) greater than or equal to 30 2. diagnosis of diabetes mellitus (either type I or II) 3. previous history of hernia recurrence 4. active smoker 5. presence of colostomy or ileostomy 6. age greater than 64 7. chronic obstructive pulmonary disease 8. chronic kidney disease 9. clinically immunocompromised.

Exclusion criteria

1. the abdomen is left open post-operatively, or 2. if the patient has a sensitivity to silver.

Design outcomes

Primary

MeasureTime frameDescription
Surgical Site ComplicationsFirst 3 months post-operativelyComposite of incidence of surgical site infection, hematoma formation, seroma formation, wound dehiscence, hernia recurrence, and fistula formation.

Secondary

MeasureTime frameDescription
Quality of life after surgery: survey3 months post-operativelyQuality of life as measured using the Hernia-Related Quality of Life Survey (HerQLes). Scoring is out of 100, with higher scores indicating better quality of life.
Cost-effectiveness3 months post-operativelyCost in dollars per quality-adjusted life year, measured using hospital length of stay, cost of complications, and cost of intervention

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026